Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06781411

Unity Cures Future (UCF) Biobank

Research scientists of the University of Central Florida College of Medicine (COM) and Burnett School of Biomedical Sciences (BSBS) conduct laboratory studies in biomedical and translational medical research for the purpose of understanding human disease and developing innovative methods for diagnosing, measuring, or treating disease or disease symptoms. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Central Florida

Orlando, Florida, 32827, United States

Location status: Recruiting

Location contact

Amoy Fraser, PhD, CCRP, PMP

CONTACT

[email protected]

4072668742

Amoy Fraser, PhD, CCRP, PMP

CONTACT

Britney-Ann Wray, BS, CTBS, CCRP

CONTACT

[email protected]

4072668742

About this study

The goal of this human tissue repository protocol is to aggregate resources and streamline the acquisition of human tissue. It is optimal for the advancement of biomedical and translational medical research that the human tissue be received under one protocol by the College of Medicine's the Clinical & Aerospace Health Research team and transferred to the COM/BSBS research scientists for laboratory testing.

This aggregation of efforts and resources through a human tissue repository protocol allows for:

  • Improvements in biomedical and translational medical research by availability of viable human tissues.
  • Reduced recruitment and enrollment burden on the Clinical & Aerospace Health Research team and the participants via pooled recruitment. Further, participants will only need to provide one informed consent. Received human tissue may be used for multiple protocols.
  • Improved data for analysis as participants will complete an online case report form containing basic demographic data; planned location and date of upcoming surgery or procedure; diagnosis; name of surgeon/doctor for the planned surgery or procedure; type of surgery or procedure; medical data; medical history; and surgery history.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • be able to read and understand English
  • scheduled for a surgery or procedure that will result in the removal of human tissue.

Exclusion criteria

  • Pregnant
  • unable to provide an informed consent
  • unable to understand or read in English
  • minors (ages under 18)
  • prisoners

Treatment and study plan

Primary outcomes

  1. Receipt of donated human tissue for research

    Time frame: 50 years

    The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology. Frequently, these studies require human tissue for testing of assays and devices.

Study contacts

Contact information is provided by the study sponsor or research team.

Britney-Ann Wray, BS, CTBS, CCRP

CONTACT

[email protected]

4072668742

Sponsors and collaborators

Lead sponsor

University of Central Florida

Other

Registry information

Official study title

Unity Cures Future (UCF) Biobank for Translational & Biomedical Research At UCF College of Medicine and Burnett School of Biomedical Sciences with Identifiable Human Tissue.

Important dates

Study start
2024
Primary completion
2075
Study completion
2075
First posted
Jan 17, 2025
Registry last updated
Jan 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.